DxTerity logo — Bringing the power of precision medicine to autoimmune disea...

DxTerity

Bringing the power of precision medicine to autoimmune disease

Founded 2006 United States Rancho Dominguez, United States 31 employees Series Unknown Total: $3.79M Biotechnology, Health Care

General Information

Company Name DxTerity
Founded Year 2006
Location United States Rancho Dominguez, United States +1
Employees 31
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when DxTerity moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About DxTerity

DxTerity, with the slogan "Bringing the power of precision medicine to autoimmune disease," is a biotechnology and health care startup founded in 2006 and headquartered in the United States. The company is pioneering the use of RNA-based immune system profiling to gain a better understanding of the root causes of immune-mediated conditions. Their ultimate goal is to provide more personalized care for autoimmune sufferers while empowering patients with detailed information about their condition, helping them navigate their complex health journey more effectively. DxTerity recently received a $252.00K venture round investment on 13 October 2021. This startup is making significant strides in the field of precision medicine for autoimmune diseases, presenting a promising opportunity for investment in the health care and biotechnology industries.

Taxonomy: Precision Medicine, Autoimmune Disease, RNA-based Immune System Profiling, Genomic Testing, Molecular Diagnostics, Oncology, Immune Response, Genomic Studies, Blood Diagnostics, Personalized Medicine, Lupus, Clinical Trials, High Frequency Genomics, Siteless Clinical Studies, Patient Recruitment

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 13 Oct 2021
Venture Round •••••• - 12 Jan 2015
Debt Financing •••••• - 17 Jan 2012
Series B •••••• - 11 May 2010
Series A •••••• - 14 Oct 2009

DxTerity Alternatives & Competitors

DxTerity vs

Every immune system has a story to tell; the key is knowing how to listen.

IPO
654 employees
Biotechnology, Health Care
DxTerity vs

Repertoire is a biotechnology company creating a new category of immune medicines for cancer and aut...

Series B
86 employees
Biotechnology, Health and Wellness
DxTerity vs

The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the N...

36 employees
Also compare with: DxTerity vs AnTolRx AnTolRx

FAQ About DxTerity

Bringing the power of precision medicine to autoimmune disease
DxTerity was founded in 2006.
DxTerity is headquartered in Rancho Dominguez, United States.
DxTerity operates in the following industries: Biotechnology, Health Care.
DxTerity has approximately 31 employees.
DxTerity has completed 5 funding rounds, raising a total of $3.79M. The latest funding stage is Series Unknown.
Top alternatives and competitors to DxTerity include Adaptive Biotechnologies Corp., Repertoire Immune Medicines, Immune Tolerance Network, AnTolRx, Revolo Biotherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DxTerity and Adaptive Biotechnologies Corp. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors DxTerity and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy